Are these ASX tech stocks finally a buy again?

Three big falls, three very different businesses.

ASX tech stocks have had a rough week.

To illustrate, on Wednesday, Xero Ltd (ASX: XRO) fell 5.2% to $98.90.

WiseTech Global Ltd (ASX: WTC) dropped 5.16% to $37.65.

These results occurred as the ASX 200 had its worst session in three months.

The question worth asking for investors is whether the selling has finally gone too far.

Blue semiconductor chip.

Image source: Getty Images

Why ASX tech stocks fell so far

The drop is not linked to any news out of the companies themselves.

Bond yields have risen sharply, with the US 10-year Treasury reaching 4.79% and Australia's long bond returning to levels last seen in 2011.

Technology businesses earn most of their profit years into the future, so a higher discount rate hits them harder than anything else on the market.

This has unfortunately been compounded by a 60% chance of a Reserve Bank rate rise this month.

Here are a few tech stocks hit particularly hard.

1. WiseTech Global

WiseTech is the most interesting name on this list.

The company's shares have fallen from a 52-week high of $99.70 to $37.65, which is a decline of more than 60%.

In its latest results, FY26 revenue rose 79% to US$1,395.9 million, helped enormously by the e2open acquisition.

Underlying EBITDA climbed 56% to US$644.5 million and free cash flow increased 43% to US$410.7 million.

The problem lies in what the future holds for the company.

FY27 guidance is for revenue growth of just 6% to 10%, and an active ACCC investigation is adding doubts in the back of investors' minds.

At 50 times earnings, WiseTech is trading at a significant multiple for a company only projected to grow revenue in the single digits.

2. Xero

Xero is the highest quality operator of the three and now is within 70 cents of its 52-week low.

FY26 operating revenue rose 31% to $2.75 billion and annualised monthly recurring revenue jumped 37% to $3.27 billion.

The company added 506,000 customers to reach 4.92 million globally, while average revenue per customer rose 23% to $55.44.

Adjusted EBITDA grew 18% to $757.4 million, though net profit fell 27% to $167.4 million on Melio acquisition costs.

Chief executive Sukhinder Singh Cassidy noted the strength of the platform:

We have powerful momentum across our markets, and delivered strong EBITDA growth while absorbing the Melio integration.

FY27 guidance points to revenue of $3.62 billion to $3.73 billion, which is another year of roughly 30% growth.

3. Life360

Life360 Inc (ASX: 360) is the highest risk of the three.

Shares have fallen nearly 40% year-to-date.

Despite this, second-quarter revenue rose 38% to US$159 million and adjusted EBITDA jumped 53% to US$31.1 million.

However, look a little deeper and the picture unravels.

Net income fell 17.8% to US$5.1 million, and the net income margin halved to 3% from 6%.

At such high multiples, margin reductions are very bad news for investors.

What could make ASX tech stocks work from here

Two things would give ASX stocks some form of relief.

The first is any sign that the Reserve Bank will not need to raise rates. That is because falling yields lift long-duration valuations, such as those belonging to tech stocks, immediately.

The second is evidence that these businesses can convert revenue growth into profit growth without having to rely on acquisitions.

Foolish takeaway

Xero looks best positioned in the short-term, because it is growing at 30% with a strong network effect and it trades near a 52-week low.

WiseTech is cheaper than it was but still carries an unresolved regulatory investigation.

In contrast, Life360 has the strongest growth and the weakest proof of profitability.

A year of falling prices has made ASX tech stocks far more interesting than they were in September 2025.

It has not yet made them safe, and anyone buying here should expect more volatility before the rate cycle settles.

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended Life360, WiseTech Global, and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

Happy man wearing a blue shirt and glasses holding a card and using buy now pay later services to purchase a product on his office computer
Technology Shares

Zip Q1 FY27 earnings: Guidance reaffirmed

Zip reveals Q1 FY27 earnings, with TTV up 18% and guidance reaffirmed for the year ahead.

Read more »

A worried man chews his fingers.
Technology Shares

NextDC shares rebound 7% from an 8-year low: Here's what brokers tip next

The ASX tech shares crashed 42% on Wednesday.

Read more »

Work colleagues discussing finance charts and graphs on a laptop computer and tablet in their office.
Technology Shares

Should I buy Xero and Zip shares with $10,000?

Both have fallen heavily, but I think their long-term opportunities remain firmly intact.

Read more »

Sport fans cheering at a game in a stadium.
Technology Shares

Could WiseTech shares smash past $100 in the next 12 months?

WiseTech shares have jumped 12% higher over the past week alone.

Read more »

IT specialist using laptop in data centre full of server racks.
Technology Shares

This small-cap ASX tech stock could more than triple in value: Broker

A new deal could mean big things for this company.

Read more »

Worried woman with hand on her mouth looks at her phone with a laptop open in front of her.
Technology Shares

NEXTDC slashes FY27 guidance after M3 Melbourne power delay

NEXTDC has cut its FY27 revenue and EBITDA guidance after delays to power upgrades at its M3 Melbourne data centre.

Read more »

A silhouette of a soldier flying a drone at sunset.
Technology Shares

Codan has issued yet another profit upgrade

Strong demand for drone technology continues to drive growth.

Read more »

A female scientist in a laboratory setting using a tablet to review data, with a male scientist working in the background.
Technology Shares

Should I buy Pro Medicus shares after its big news?

Another US contract adds to a growth story I think still has a long way to run.

Read more »